Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?

被引：106

作者：

Avet-Loiseau, Herve ^{[1
,2
]}

Malard, Florent ^{[2
]}

Campion, Loic ^{[3
]}

Magrangeas, Florence ^{[2
]}

Sebban, Catherine ^{[4
]}

Lioure, Bruno ^{[5
]}

Decaux, Olivier ^{[6
]}

Lamy, Thierry ^{[7
]}

Legros, Laurence ^{[8
]}

Fuzibet, Jean-Gabriel ^{[9
]}

Michallet, Mauricette ^{[10
]}

Corront, Bernadette ^{[11
]}

Lenain, Pascal ^{[12
]}

Hulin, Cyrille ^{[13
]}

Mathiot, Claire ^{[14
]}

Attal, Michel ^{[15
]}

Facon, Thierry ^{[16
]}

Harousseau, Jean-Luc ^{[17
]}

Minvielle, Stephane ^{[2
]}

Moreau, Philippe ^{[18
]}

机构：

[1] Univ Hosp, Hematol Lab, Inst Biol, F-44093 Nantes, France

[2] INSERM, U892, Nantes, France

[3] Ctr Rene Gauducheau, Dept Stat, F-44035 Nantes, France

[4] Ctr Leon Berard, Dept Hematol, F-69373 Lyon, France

[5] Univ Hosp, Dept Hematol, Strasbourg, France

[6] Univ Hosp, Dept Internal Med, Rennes, France

[7] Univ Hosp, Dept Hematol, Rennes, France

[8] Univ Hosp, Dept Hematol, Nice, France

[9] Univ Hosp, Dept Internal Med, Nice, France

[10] Univ Hosp, Dept Hematol, Lyon, France

[11] Univ Hosp, Dept Hematol, Annecy, France

[12] Ctr Francois Baclesse, Dept Hematol, Rouen, France

[13] Univ Hosp, Dept Hematol, Nancy, France

[14] Inst Curie, Hematol Lab, Paris, France

[15] Univ Hosp, Dept Hematol, Toulouse, France

[16] Univ Hosp, Dept Hematol, Lille, France

[17] Ctr Rene Gauducheau, Dept Hematol, F-44035 Nantes, France

[18] Univ Hosp, Dept Hematol, Nantes, France

来源：

BLOOD | 2011年 / 117卷 / 06期

关键词：

STEM-CELL TRANSPLANTATION; C-MAF; MAINTENANCE; THALIDOMIDE; EXPRESSION; SURVIVAL; THERAPY; TRIAL; GENE;

D O I：

10.1182/blood-2010-07-295105

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Many trials in myeloma are stratified on cytogenetic abnormalities. Among them, the most commonly chosen are the t(4;14), the del(17p), and the t(14;16). If data are well established for t(4;14) and del(17p), very few data support the use of t(14;16). To address this issue, we retro-spectively analyzed 1003 patients with newly diagnosed myeloma for this abnormality. We identified 32 patients with the t(14;16). Compared with patients lacking the t(14;16), we did not observe any difference in overall survival (P = .28). Moreover, in multivariate analyses, the t(14;16) was not prognostic (P = .39). In conclusion, our data do not support the use of t(14;16)-specific probes in the diagnostic panels of multiple myeloma. (Blood. 2011; 117(6): 2009-2011)

引用

页码：2009 / 2011

页数：3

共 50 条

[1] Still high risk? A review of translocation t(14;16) in multiple myeloma
Mian, Hira
Kaiser, Martin
Fonseca, Rafael
AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (10) : 1979 - 1987
[2] Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions
Schavgoulidze, Anais
Perrot, Aurore
Cazaubiel, Titouan
Leleu, Xavier
Montes, Lydia
Jacquet, Caroline
Belhadj, Karim
Brechignac, Sabine
Frenzel, Laurent
Chalopin, Thomas
Rey, Philippe
Schiano de Collela, Jean-Marc
Dib, Mamoun
Caillot, Denis
Macro, Margaret
Fontan, Jean
Buisson, Laure
Pavageau, Luka
Roussel, Murielle
Manier, Salomon
Mohty, Mohamad
Martinet, Ludovic
Avet-Loiseau, Herve
Corre, Jill
BLOOD CANCER JOURNAL, 2023, 13 (01)
[3] A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma
Goldman-Mazur, Sarah
Jurczyszyn, Artur
Castillo, Jorge J.
Waszczuk-Gajda, Anna
Grzasko, Norbert
Radocha, Jakub
Bittrich, Max
Kortuem, K. Martin
Gozzetti, Alessandro
Usnarska-Zubkiewicz, Lidia
Davila Valls, Julio
Jayabalan, David S.
Niesvizky, Ruben
Kelman, Julia
Coriu, Daniel
Rosinol, Laura
Szukalski, Lukasz
Gonzalez-Calle, Veronica
Mateos, Maria V.
Jamroziak, Krzysztof
Hus, Iwona
Avivi, Irit
Cohen, Yael
Suska, Anna
Chappell, Aimee
Madduri, Deepu
Chhabra, Saurabh
Kleman, Ariel
Hari, Parameswaran
Delforge, Michel
Robak, Pawel
Gentile, Massimo
Kozlowska, Izabela
Goldberg, Stuart L.
Czepiel, Jacek
Silbermann, Rebecca
Olszewski, Adam J.
Barth, Peter
Mikala, Gabor
Chim, Chor S.
Dlugosz-Danecka, Monika
Grosicki, Sebastian
Vesole, David H.
AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (05) : 503 - 509
[4] Clinical and prognostic significance of t(4;14) translocation in multiple myeloma in the era of novel agents
Sato, Shuku
Kamata, Wataru
Okada, Satomi
Tamai, Yotaro
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (02) : 207 - 213
[5] Prognostic value of t(4;14) translocation in newly diagnosed multiple myeloma patients in novel agent era
Geng, Chuanying
Yang, Guangzhong
Zhou, Huixing
Wang, Huijuan
Li, Yanchen
Leng, Yun
Zhang, Zhiyao
Jian, Yuan
Chen, Wenming
HEMATOLOGY, 2023, 28 (01)
[6] MYEOV is a prognostic factor in multiple myeloma
Moreaux, Jerome
Hose, Dirk
Bonnefond, Amelie
Reme, Thierry
Robert, Nicolas
Goldschmidt, Hartmut
Klein, Bernard
EXPERIMENTAL HEMATOLOGY, 2010, 38 (12) : 1189 - 1198
[7] A Novel Transgenic Mouse Model of the Human Multiple Myeloma Chromosomal Translocation t(14;16)(q32;q23)
Morito, Naoki
Yoh, Keigyou
Maeda, Atsuko
Nakano, Takako
Fujita, Akiko
Kusakabe, Manabu
Hamada, Michito
Kudo, Takashi
Yamagata, Kunihiro
Takahashi, Satoru
CANCER RESEARCH, 2011, 71 (02) : 339 - 348
[8] The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma
Rasche, Leo
Angtuaco, Edgardo J.
Alpe, Terri L.
Gershner, Grant H.
McDonald, James E.
Samant, Rohan S.
Kumar, Manoj
Van Hemert, Rudy
Epstein, Joshua
Deshpande, Shayu
Tytarenko, Ruslana
Yaccoby, Shmuel
Hillengass, Jens
Thanendrarajan, Sharmilan
Schinke, Carolina
van Rhee, Frits
Zangari, Maurizio
Walker, Brian A.
Barlogie, Bart
Morgan, Gareth J.
Davies, Faith E.
Weinhold, Niels
BLOOD, 2018, 132 (01) : 59 - 66
[9] Early monoclonal protein decline pattern is an independent prognostic factor in patients with multiple myeloma
Xu, Limei
Liu, Junru
Chen, Meilan
Kuang, Lifen
Huang, Beihui
Gu, Jingli
Li, Juan
ANNALS OF HEMATOLOGY, 2020, 99 (03) : 581 - 589
[10] Multiple myeloma-associated amyloidosis is an independent high-risk prognostic factor
Vela-Ojeda, J.
Garcia-Ruiz Esparza, M. A.
Padilla-Gonzalez, Y.
Sanchez-Cortes, E.
Garcia-Chavez, J.
Montiel-Cervantes, L.
Reyes-Maldonado, E.
Majluf-Cruz, A.
Mayani, H.
ANNALS OF HEMATOLOGY, 2009, 88 (01) : 59 - 66

← 1 2 3 4 5 →